Chantix

Chantix May Increase Risk of Heart Attacks

Chantix (veranicline), manufactured by Pfizer, Inc., is a smoking cessation drug approved by the Food and Drug Administration (FDA) in 2006.

In 2009 in response to hundreds of reports the FDA required a “Black Box” warning to be added to Chantix side effects such as depression, suicidal thoughts, attempted suicide, and suicide.  A Black Box warning is the strongest warning the FDA can impose on a drug, short of taking the drug off the market.

Chantix has been linked to a number of other side effects including new onset diabetes and Stevens-Johnson syndrome.

On June 17, 2011 the FDA warned that some users of Chantix may face an increased risk of heart attacks and other heart problems.

The Plymale Law Firm is handling litigation related to these injuries nationwide.

If you or someone you love has suffered from a heart attack or from suicide or attempted suicide after taking Chantix, you should contact the Plymale Law Firm for a free consultation by filling out the form on this page or by calling us at (877) 328-7670.

Comments are closed.